The mission of the American Heart Association/American Stroke Association is to build healthier lives, free of cardiovascular diseases and stroke. We currently have almost 33,000 Professional Members that support our mission through their outstanding gifts of time, dedication and heart.
AHA/ASA Professional Members affiliate and interact with one or more of these scientific councils that match their specialty or classification, depending on the membership level selected.
The Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) contributes to the mission and objectives of the American Heart Association (AHA) through efforts in the fields of arteriosclerosis, thrombosis and vascular biology. The council advances and coordinates research, addresses prevention, improves methods for diagnosis and treatment, and works actively with other organizations concerned with these issues. The council disseminates reliable information related to these fields through its annual conference, many awards and lectures, and the AHA's journal, Arteriosclerosis, Thrombosis, and Vascular Biology.
Steven R. Lentz, MD, PhD, FAHA
Chair, Council on Arteriosclerosis, Thrombosis and Vascular Biology
The American Heart Association (AHA) created the Council on Basic Cardiovascular Sciences (BCVS) in 1999 to promote research and education. Our goal is to improve understanding of mechanisms of basic cardiovascular regulation to support the development of new therapies and insights into clinical cardiovascular disease. Special emphasis is placed on integrating molecular/cellular and physiological approaches to address problems relating to functional genomics, cell signaling, myocardial biology, circulatory physiology, pathophysiology and peripheral vascular disease.
Ronglih Liao, PhD, FAHA
Chair, Council on Basic Cardiovascular Sciences
The American Heart Association's (AHA) strategic goal to reduce coronary heart disease, stroke and risk by 20 percent by the year 2020 has led to an emphasis on the importance of resuscitation and the chain of survival in AHA activities and use of resources. The Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation (3CPR) bench-to-bedside and community approach ranges from integrated cardiopulmonary physiology to issues of critical care, emergency cardiovascular care and CPR. Pulmonary hypertension and regulation of the pulmonary circulation have historically been areas of investigation for many of our council members. The council is keenly interested in promoting approaches that include clinical care, clinical research and basic science.
Council activities focus on developing research interests and careers of young investigators, writing scientific statements for the AHA, supporting scientific meetings and providing representation on various American Heart Association committees.
Benjamin S. Abella, MD, MPhil, FAHA
Chair, Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation
The mission of the Council on Cardiovascular and Stroke Nursing (CVSN) is to accelerate the discovery, translation and application of knowledge to promote and improve overall cardiovascular health. Our efforts focus on contributing nursing’s biopsychosocial expertise to American Heart Association's (AHA) global agenda to promote ideal cardiovascular health, quality of life, and heart healthy lifestyles and environments.
Deborah Chyun, PhD, RN, FAHA, FAAN
Chair, Council on Cardiovascular and Stroke Nursing
The Council on Cardiovascular Disease in the Young (CVDY) actively supports the mission to improve the health of children and adults with congenital heart disease and cardiovascular disease acquired during childhood through research, education, prevention and advocacy.
Bradley S. Marino, MD, MPP, MSCE, FAHA
Chair, Council on Cardiovascular Disease in the Young
The mission of the Council on Cardiovascular Radiology and Intervention (CVRI) is to provide leadership to the American Heart Association (AHA) and American Stroke Association to reduce death and disability from cardiovascular, peripheral vascular and cerebrovascular diseases, using diagnostic and functional imaging and imaging-directed interventions.
Constantino Peña, MD, FAHA
Chair, Council on Cardiovascular Radiology and Intervention
Council members are American Heart Association (AHA) volunteers. The Council on Cardiovascular Surgery and Anesthesia (CVSA) includes surgeons, anesthesiologists and scientists interested in cardiac, vascular and thoracic interventions. The council is involved in a full range of American Heart Association activities, including basic science and clinical trials. Specific goals of the council are to improve application of established surgical procedures and anesthetic techniques, increase awareness of new issues in the field of cardiovascular surgery and anesthesia, and disseminate new knowledge to increase the number of patients who may benefit from safer and more effective surgical treatment. All cardiovascular surgeons, thoracic surgeons, anesthesiologists and other professional colleagues are encouraged to become council members.
Marc Ruel, MD, MPH, FAHA
Chair, Council on Cardiovascular Surgery and Anesthesia
The purpose of the Council on Clinical Cardiology (CLCD) is to achieve the objectives of the American Heart Association (AHA) in the field of clinical cardiology, to promote excellence in clinical care and to foster the professional development and education of clinical cardiologists. Through council-sponsored symposia, panels and scientific conferences, members can access new developments in the field and interpret and promote clinical cardiology to professional and lay audiences.
Ileana L. Piña, MD, MPH, FAHA, FACC
Chair, Council on Clinical Cardiology
The Council on Epidemiology and Prevention (EPI) focuses on population-based approaches to preventing cardiovascular diseases. The mission of the American Heart Association (AHA) Council on Epidemiology and Prevention is to lead the discovery and translation of science related to the distribution and determinants of cardiovascular disease, with an emphasis on population approaches to prevent cardiovascular disease and improve cardiovascular health.
Donald M. Lloyd-Jones, MD, ScM, FAHA
Chair, Council on Epidemiology and Prevention
The mission of the American Heart Association (AHA) Council on Functional Genomics and Translational Biology (FGTB) is to advance discoveries from genetics, systems and translational biology and to facilitate their application in global cardiovascular health and disease.
Svati Shah, MD, MS, MHS, FAHA
Chair, Council on Functional Genomics and Translational Biology
The mission of the American Heart Association's Council on Hypertension is to help achieve the association's objectives of "building healthier lives, free of cardiovascular diseases and stroke” by promoting the discovery, translation and dissemination of basic, clinical and population-based research and supporting cutting-edge clinical practice and education on the causes, consequences and treatment of hypertension.
Christopher S. Wilcox, MD, PhD, FRCP(UK), FACP, FAHA
Chair, Council on Hypertension
The Council on Lifestyle and Cardiometabolic Health promotes the expansion and exchange of knowledge with the ultimate goal of improving cardiovascular health across the lifespan. Our council promotes basic, clinical, epidemiological, and translational science related to nutrition, lipids, obesity, diabetes, physical activity, and behavior change.
Jean-Pierre Després, PhD, FAHA, FIAS
Chair, Council on Lifestyle and Cardiometabolic Health
The Council on Peripheral Vascular Disease (PVD) seeks to integrate the academic and clinical missions of all interdisciplinary vascular health professionals in order to expand professional and public vascular education; to advance the basic science and clinical research and evidence based practice; and to thereby improve clinical outcomes of individuals with PVD.
Joshua A. Beckman, MD, MS, FAHA
Chair, Council on Peripheral Vascular Disease
The Council on Quality of Care and Outcomes Research (QCOR) provides a forum for a multidisciplinary group of volunteers committed to making a substantial contribution to reducing the burden of heart disease and stroke through improving healthcare quality and patient outcomes.
Paul Heidenreich, MD, MS, FAHA
Chair, Council on Quality of Care and Outcomes Research
The American Heart Association (AHA) Council on the Kidney in Cardiovascular Disease (KCVD) mission is to reduce cardiovascular-related disability and death through research, communication, advocacy and education about the kidney.
Kidney disease is a major cause and a consequence of cardiovascular disease. Chronic renal insufficiency is thought to be an independent risk factor for developing hypertension, vascular disease, atherosclerosis and other morbidity and mortality risk factors. Patients with cardiovascular disease and diabetes are also at high risk for developing kidney failure.
Núria M. Pastor-Soler, MD, PhD, FASN
Chair, Council on the Kidney in Cardiovascular Disease
The American Heart Association’s mission is “building healthier lives, free of cardiovascular diseases and stroke.” The Stroke Council, one of 16 scientific councils within the American Heart Association, is uniquely dedicated to advancing the science of stroke prevention, treatment and recovery through research and education. The Stroke Council develops scientifically based publications, meetings, professional education, and training programs and supports the American Stroke Association’s work in translating stroke-related science into effective initiatives and products for the public, healthcare professionals, healthcare facilities and policy makers.
Colin P. Derdeyn, MD, FAHA
Chair, Stroke Council